NIKI · XBRL financial data
Niki BioSolutions financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (NIKI's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | 1,542 | 1,296 | 431 | — | — |
| Cost of revenue | — | 1,460 | 1,216 | 421 | — | — |
| Research and development | 11,587 | 10,870 | 9,220 | 5,198 | 2,195 | 353 |
| General and administrative | 4,853 | 5,409 | 5,220 | 1,931 | 669 | 573 |
| Total operating expenses | 21,187 | 20,749 | 18,805 | 31 | — | — |
| Other operating income (expense) | — | — | — | (1,068) | (273) | 171 |
| Net income (loss) | 6,311 | (27,114) | (11,525) | (2,825) | (4,268) | (1,363) |
| Earnings per share, basic USD per share | 2.03 | (0.71) | (2.75) | (0.62) | (0.78) | (0.19) |
| Earnings per share, diluted USD per share | 0.20 | (0.71) | (2.75) | (0.62) | (0.78) | (0.19) |
| Weighted average shares, basic thousands of shares | 31,136 | 35,034 | 3,569 | 4,521 | 5,453 | 7,352 |
| Weighted average shares, diluted thousands of shares | 31,534 | 35,034 | 3,569 | 4,521 | 5,453 | 7,352 |
- † Share count changed about 1/10 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (NIKI's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 3,625 | 8,261 | 5,013 | 2,005 | 874 | 3,453 |
| Marketable securities | — | 237 | 102 | — | — | — |
| Accounts receivable | 62 | 79 | 174 | 48 | — | — |
| Inventory | 39 | 36 | 28 | — | — | — |
| Prepaid and other current assets | 1,379 | 593 | 744 | 422 | 85 | 140 |
| Total current assets | 33,657 | 12,688 | 7,068 | 2,476 | 960 | 3,593 |
| Property and equipment, net | 4,686 | 3,731 | 2,825 | 1,664 | — | — |
| Right-of-use asset | 547 | 154 | 347 | 182 | — | — |
| Total assets | 44,231 | 21,907 | 20,867 | 20,640 | 16,130 | 18,691 |
| Total current liabilities | 3,869 | 4,377 | 12,503 | 2,099 | 4,339 | 4,594 |
| Long-term debt | 296 | 296 | 130 | — | — | — |
| Lease liability, non-current | 155 | 24 | 31 | 99 | 14 | — |
| Total liabilities | 6,079 | 4,401 | 13,034 | 5,257 | 4,353 | 4,900 |
| Accumulated deficit | (30,489) | (55,538) | (65,337) | (68,162) | (72,430) | (73,793) |
| Total stockholders' equity | 41,834 | 23,607 | 15,712 | 24,846 | 21,135 | 23,115 |
| Total liabilities and equity | 44,231 | 21,907 | 20,867 | 20,640 | 16,130 | 18,691 |
- † Share count changed about 1/10 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (NIKI's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 6,311 | (27,114) | (11,525) | (2,825) | (4,268) | (1,363) |
| Stock-based compensation | 1,479 | 1,682 | 1,647 | 1,265 | — | — |
| Depreciation and amortization | 1,335 | 1,193 | 1,208 | 1,125 | — | — |
| Net cash from operating activities | (15,932) | (14,652) | (12,319) | (7,724) | (1,190) | (1,837) |
| Purchases of property and equipment | 161 | 132 | 187 | 3 | — | — |
| Net cash from investing activities | 1,842 | 16,507 | 2,445 | 625 | 59 | — |
| Proceeds from issuing common stock | 17,497 | 4,000 | — | 1,576 | — | 3,070 |
| Net cash from financing activities | 12,422 | 2,781 | 6,625 | 4,092 | — | 4,415 |
| Net change in cash | (1,668) | 4,636 | (3,249) | — | — | — |
- † Share count changed about 1/10 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3829 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3829 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Niki BioSolutions | 3,453 | not reported | year only | not reported | — | 20-FDec 31, 2025 |
| Autoscope Technologies | 3,411 | 3,155 | 210* | 5.4M | — | 10-QSep 30, 2022 |
| Birchtech | 11,836 | 3,791 | (2,790)* | 26.3M | 4.2 quarters | 10-QJun 30, 2026 |
| Flexpoint Sensor Systems | 0.4 | 55* | (76)* | 125.6M | 0.0 quarters | 10-KDec 31, 2021 |
| Geospace Technologies | 2,833 | 15,804 | (10,688)* | 12.9M | 0.3 quarters | 10-QJun 30, 2026 |
| Mirion Technologies | 408,700 | 277,800 | 59,200* | not reported | — | 10-QSep 30, 2026 |
| Onto Innovation | 1,253,205 | 343,129 | 61,507* | 49.1M | — | 10-QJun 30, 2026 |
| Owlet | 30,948 | 33,865 | (92)* | 29.2M | 336.4 quarters | 10-QJun 30, 2026 |
| Quantum-Si | 23,653 | 344 | (18,444)* | not reported | 6.1 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.